<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03534986</url>
  </required_header>
  <id_info>
    <org_study_id>2017-02</org_study_id>
    <nct_id>NCT03534986</nct_id>
  </id_info>
  <brief_title>Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements</brief_title>
  <official_title>Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Biophysics Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>International Biophysics Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced
      Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and
      Tidal Volume is investigated during use of several products and comparing to baseline values.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be broken into three (3) arms:

        -  AffloVest® &amp; The Vest®

        -  AffloVest® &amp; inCourage®

        -  AffloVest® &amp; SmartVest® Subjects will be randomly assigned to an arm. Within each arm,
           the order of products will be also randomized.

      Baseline spirometry (Forced Expiratory Volume (FEV1), Forced Vital Capacity (FVC), Peak
      Expiratory Flow (PEF), Forced Expiratory Flow (FEF25-75%) and Tidal Volume (TV)) will be
      taken at the beginning, middle and end of each series of measurements with each subject,
      without any device on the subject.

      A product (AffloVest or Compressor-based vest) will be placed onto subject and turned ON to
      the highest frequency and intensity settings. Then the subject will be given a certain period
      of time to adjust and spirometry measurements will then be repeated, then The product will be
      removed and the subject will be allowed a recovery period, then the other product will be
      placed on the subject, turned ON and spirometry measurements will repeated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 20, 2018</start_date>
  <completion_date type="Actual">March 16, 2018</completion_date>
  <primary_completion_date type="Actual">March 16, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spirometry Measurements</measure>
    <time_frame>30 minutes</time_frame>
    <description>TV, PEF, FVC, FEV1, FEF25-75%</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>AffloVest The Vest Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AffloVest inCourage Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AffloVest SmartVest Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>International Biophysics AffloVest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest The Vest Arm</arm_group_label>
    <arm_group_label>AffloVest inCourage Arm</arm_group_label>
    <arm_group_label>AffloVest SmartVest Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hill-Rom The Vest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest The Vest Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respirtech inCourage</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest inCourage Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electromed SmartVest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest SmartVest Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subject, ages 18 - 50

        Exclusion Criteria:

          -  Non-ambulatory, diagnosed neuromuscular disorder, currently using any type of
             oscillation vest therapy, diagnosed co-morbid condition (i.e. lung cancer, other lung
             disorder or disease), currently enrolled in a medical research study, non-English
             speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W O'Brien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PDS Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PDS Research</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2018</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

